Filing Details
Neurogene Inc. (NASDAQ:NGNE) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event.
8k filedNASDAQ:NGNE
Neurogene Inc. (NGNE) Reports Material Event to SEC
Filing Details Neurogene Inc. (NASDAQ:NGNE) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event. Market Context Neurogene…
Market Context
Neurogene Inc.'s stock currently trades at $32.28 with a market capitalization of $329.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Neurogene Inc.'s stock.
All SEC filings for Neurogene Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NGNE Stock Page
Frequently Asked Questions
Where can I read NGNE's SEC filings?
Browse all filings on our NGNE SEC filings page.
What types of SEC filings does Neurogene Inc. file?
Public companies like Neurogene Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.